Company / FCF Margin
Ovid Therapeutics Inc. FCF Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-9898.8%
FY2025
5-year range
-11689.0% / 56.8%
FY2022-FY2025
Trend
+15.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin returned to growth in FY2025 after 2 years of decline, reaching -9898.8%.
Based on SEC 10-K filings.
-9898.8% in FY2025 with a 3-year CAGR of -9955.6%.
Declined from -3756.6% to -9898.8% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -9955.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 15.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -9898.8% | +15.3% |
| FY2024 | -11689.0% | -211.2% |
| FY2023 | -3756.6% | -6710.2% |
| FY2022 | 56.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026